Evidence map›Paper›PMID 28494191›Full record

ReviewRenal failure2017

Biomarker for early renal microvascular and diabetic kidney diseases.

Narisa Futrakul, Prasit Futrakul

Abstract readReview
In one paragraph

Review in Renal failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Urinary biomarkers of diabetic kidney disease.World journal of diabetes · 2026
    Review
  2. Article
  3. Article
  4. Understanding Renal Tubular Function: Key Mechanisms, Clinical Relevance, and Comprehensive Urine Assessment.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Quantitative Methods in Abdominal MRI: Perfusion Imaging.Topics in magnetic resonance imaging : TMRI · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Narisa Futrakula Department of Physiology, Faculty of Medicine , King Chulalongkorn Memorial Hospital, Chulalongkorn University , Bangkok , Thailand.
Prasit Futrakulb Academy of Science , The Royal Institute of Thailand and Bhumirajanagarindra Kidney Institute , Bangkok , Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recognition of early stage of diabetic kidney disease, under common practice using biomarkers, namely microalbuminuria, serum creatinine level above 1 mg/dL and accepted definition of diabetic kidney disease associated with creatinine clearance value below 60 mL/min/1.73 m

Indexed as

AlbuminuriaBiomarkersCreatinineCystatin CDiabetes Mellitus, Type 2Diabetic NephropathiesDisease ProgressionEndostatinsGlomerular Filtration RateHumansIschemiaKidneyMagnesiumMicrovesselsRenal EliminationBiomarkersCreatinineCystatin CEndostatinsMagnesiumDiabetic kidney diseaseendostatinFE Mgrenal hemodynamicsrenal microvascular disease

Identifiers

PMID28494191
PMCPMC6014362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.